Intermittent fasting – periods of eating little or nothing interspersed with normal food consumption – isn't an effective way ...
Following the frequent suspicions regarding the safety of cholesterol-lowering drugs in the pre-statin era,1 statins have been a recurrent object of various concerns and alarming news. For example, ...
Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III Trial Earlier detection of cancer offers an opportunity to ...
Research indicates that many statin therapy side effects are not supported by evidence, suggesting a need for revised ...
Thought LeadersAoife Hayes, Kevin O'Regan & Julie ScanlonClinical Trials Assitant, Operations Manager & Quality Assurance ManagerAtlantia Clinical Trials Food clinical trials may not be as familiar to ...
Elemento is the director of the Englander Institute for Precision Medicine at Weill Cornell Medicine. Sternberg is the clinical director of the Englander Institute for Precision Medicine. Khozin is ...
Statin labels should be revised to reflect their safety and to hopefully spur better uptake and adherence, say experts.
Background A more nuanced understanding of behavioural responses to incentives over time, particularly after they are removed, could guide more effective interventions. In this study, we build on the ...
Amid the brighter spotlights being directed at data use in clinical trials, synthetic control arms represent a unique approach. Synthetic control arms use statistical methods to create a virtual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results